Catalent, Somerset
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...
U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading ...
As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. Wednesday, Sen. Elizabeth Warren ...
Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said. ** Private ...
Catalent, Inc. has a 12 month low of $31.80 and a 12 month high of $61.20. The company has a market cap of $10.86 billion, a price-to-earnings ratio of -9.84, a PEG ratio of 1.88 and a beta of 1. ...
Catalent, Inc. (NYSE: CTLT) announced that it has completed the expansion of its clinical supply facility in Schorndorf, Germany. The Schorndorf site, Catalent's flagship European facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback